Inventor · disambiguated record
John J. Chaber
Also filed as: CHABER JOHN · CHABER JOHN J
10 granted patents·5 pending applications·26 citations·filing 2008–2023
86Inventor score
Top patents by PatentIndex Score
15 records- 0195US9493470B2Crystalline forms of 3-(imidazo[1,2-B] pyridazin-3-ylethynyl)-4-methyl-N-{4-[(4-methylpiperazin-1-yl) methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride saltARIAD PHARMA INC·Filed 2013·Granted Nov 15, 2016·16 cites·17 claims
- 0289US10125136B2Crystalline forms of 3-(imidazo[1,2-B] pyridazin-3-ylethynyl)-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride saltARIAD PHARMA INC·Filed 2016·Granted Nov 13, 2018·3 cites·12 claims
- 0388US10662197B2Crystalline forms of 3-(imidazo[1,2-b)pyridazin-3-ylethynyl)-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride saltARIAD PHARMA INC·Filed 2018·Granted May 26, 2020·4 cites·11 claims
- 0486US11091459B2Niraparib compositionsTESARO INC·Filed 2019·Granted Aug 17, 2021·3 cites·30 claims
- 0584US2024083902A1Crystalline forms of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-n-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride saltARIAD PHARMA INC·Filed 2023·Application pending·0 cites
- 0679US11192896B2Crystalline forms of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride saltARIAD PHARMA INC·Filed 2021·Granted Dec 7, 2021·0 cites·18 claims
- 0778US11192895B2Crystalline forms of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-n-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride saltARIAD PHARMA INC·Filed 2021·Granted Dec 7, 2021·0 cites·24 claims
- 0878US11192897B2Crystalline forms of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride saltARIAD PHARMA INC·Filed 2021·Granted Dec 7, 2021·0 cites·23 claims
- 0977US11384086B2Crystalline forms of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-n-{4-[(4-methylpiperazin-1- yl)methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride saltARIAD PHARMA INC·Filed 2021·Granted Jul 12, 2022·0 cites·19 claims
- 1074US11279705B2Crystalline forms of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-n-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride saltARIAD PHARMA INC·Filed 2020·Granted Mar 22, 2022·0 cites·3 claims
- 1173US2023416223A1Niraparib CompositionsTESARO INC·Filed 2023·Application pending·0 cites
- 1268US11673877B2Niraparib compositionsTESARO INC·Filed 2021·Granted Jun 13, 2023·0 cites·20 claims
- 1358US2009214634A1Compositions and methods for the treatment of bladder cancerINDEVUS PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 1442US2021030735A1Pediatric niraparib formulations and pediatric treatment methodsTESARO INC·Filed 2019·Application pending·0 cites
- 1541US2015190413A1Compositions and methods for the treatment of bladder cancerENDO PHARMACEUTICALS SOLUTIONS·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →